Visual Atlas · Cluster companion · 04

Medication interactions

Some interactions blunt the effect, some change it, and one carries a serious safety risk. Read this before anything else if you take a prescription medication — and treat it as a prompt to talk to a doctor.

90-second quick read · deeper research available

Need the deeper research library?

This is the 90-second cliff-note read on imicrodosing.net. For cited research context, terminology, and broader education, use the full .org research library.

Read the full medication-interactions research →Browse related 90-second reads →

SSRIsCan blunt effects

LithiumSerious risk

Doctor firstNon-negotiable

In brief

Psilocybin interacts with several common medication classes. SSRIs and SNRIs can blunt psychedelic effects over time by downregulating 5-HT2A receptors. MAOIs can intensify and prolong effects. The most serious concern is lithium: combining lithium with psychedelics has been associated with seizures and is widely treated as a combination to avoid.

This entry is informational, not a clearance to combine anything. Do not stop a prescribed medication without medical guidance, and do not combine psilocybin with a medication without speaking to a doctor first. The rule is simple: check before you start, and treat lithium as a hard stop until a clinician says otherwise.

Visual walkthrough

Cover slide introducing medication-interaction questions that require individualized clinical review.

Slide grouping possible interaction patterns while noting that evidence quality differs by medicine.

Slide discussing evidence that SSRIs and SNRIs may alter psilocybin effects; controlled and observational findings are not identical.

Slide noting seizure reports involving lithium and classic psychedelics; the evidence comes largely from case and online-report data.

Slide advising against changing prescribed medication without a qualified prescriber.

Closing slide emphasizing medication review with a clinician or pharmacist.

1 / 6

Swipe or tap the arrows to move through 6 slides

Three categories of interaction

SSRIs and SNRIs may alter effects

Survey data report weaker psilocybin effects more often with SSRIs and SNRIs, while controlled findings are mixed. Safety and effectiveness cannot be predicted from receptor theory alone.

Do not stop medication alone

If you take an antidepressant, do not discontinue it to microdose without medical supervision. Abrupt discontinuation carries its own risks independent of psilocybin.

MAOIs intensify

Direct psilocybin–MAOI interaction data are limited. Because MAOIs can create serious interactions with many serotonergic substances, this combination requires individualized medical review.

Lithium is the serious one

An analysis of online reports found a concerning seizure signal when lithium was combined with classic psychedelics. The evidence is not a controlled trial, but it supports avoiding unsupervised combination and seeking clinical advice.

Other classes warrant checking

Tramadol, some stimulants, and other serotonergic or seizure-threshold-lowering drugs warrant a clinician check. The general principle is that polypharmacy needs professional review.

The operative rule

Check before you start. This entry is educational; it does not replace a conversation with a prescriber who knows your full medication list.

What the data shows — and how strong it is

Strong Clinical + mechanisticModerate Survey + trackingEarly Promising, developingAnecdotal Widely reported only

Strong

Strong — lithium cautionLithium evidence is based largely on case and online-report data rather than controlled trials. The observed seizure signal is serious enough to require clinical caution.

Moderate

Moderate — SSRI bluntingSurvey reports suggest attenuation for many SSRI/SNRI users, while controlled findings are mixed. The magnitude and clinical relevance vary.

Early

Early — many other combinationsFor many less-common medications, interaction data is sparse. Absence of evidence is not evidence of safety — these warrant individual clinical review.

Verdict

Interaction evidence varies by medicine and person. Do not stop prescribed medication or combine substances based on a website.

Common questions

Answered directly

Q · 01

Can I microdose psilocybin while taking an SSRI?

Speak to your doctor first. Long-term SSRI use can downregulate the 5-HT2A receptors that psilocybin acts on, which tends to blunt the effect. More importantly, do not stop a prescribed antidepressant to microdose without medical supervision, because abrupt discontinuation carries its own risks.

Q · 02

Is it dangerous to combine psilocybin with lithium?

Lithium combined with classic psychedelics has a concerning seizure signal in case and online-report data. Do not combine them without explicit medical guidance.

Q · 03

Do MAOIs change the effect of psilocybin?

Direct interaction evidence is limited. MAOIs have clinically important interaction potential with many serotonergic substances, so a prescriber or pharmacist should review any proposed combination.

Product-format context

For product-format context, see the iMicrodosing.com products and client support.

View products & support →

← PreviousFormats compared Next →US legal landscape